Literature DB >> 315804

Human leukocyte interferon preparation blocks granulopoietic differentiation.

D S Verma, G Spitzer, J U Gutterman, A R Zander, K B McCredie, K A Dicke.   

Abstract

Since interferon administration in the treatment of some malignant conditions has been reported to cause leukopenia, we studied the effects of human leukocyte interferon preparation (HLIF) on myelopoiesis in vitro. The continual presence of HLIF in semisolid agar cultures caused a progressive decline in colony and a rise in cluster incidence with increasing concentrations of interferon. The total plating efficiency, however, remained nearly constant, regardless of the HLIF doses used. Morphological examination of the clusters demonstrated a progressively increasing percentage of immature granulocytic precursors with increasing HLIF concentrations. This suggests that HLIF causes leukopenia by blocking differentiation of marrow myeloid precursors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 315804

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  BCR/ABL induces multiple abnormalities of cytoskeletal function.

Authors:  R Salgia; J L Li; D S Ewaniuk; W Pear; E Pisick; S A Burky; T Ernst; M Sattler; L B Chen; J D Griffin
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia.

Authors:  O Kloke; R Becher; N Niederle
Journal:  Blut       Date:  1987-11

3.  Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes.

Authors:  S W Mamus; S Beck-Schroeder; E D Zanjani
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

4.  Effects of human alpha-interferon on granulocyte-macrophage progenitor cells (CFU-GM) in vitro.

Authors:  J S Schwamborn; R M Nickels; B D Katthagen; H W Pees; P G Scheurlen
Journal:  Blut       Date:  1988-03

5.  A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs.

Authors:  Michael F Denny; Srilakshmi Yalavarthi; Wenpu Zhao; Seth G Thacker; Marc Anderson; Ashley R Sandy; W Joseph McCune; Mariana J Kaplan
Journal:  J Immunol       Date:  2010-02-17       Impact factor: 5.422

Review 6.  Cytokine therapeutics: lessons from interferon alpha.

Authors:  J U Gutterman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

7.  Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders.

Authors:  H Ludwig; W Linkesch; H Gisslinger; E Fritz; H Sinzinger; T Radaszkiewicz; A Chott; R Flener; M Micksche
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

8.  Sensitivity of Ph 1 + CFU-GM to human recombinant interferon alpha and gamma alone and in combination.

Authors:  G Visani; D Russo; D Damiani; S Rizzi; M R Motta; R M Lemoli; C Poluzzi; R Fanin; E Zuffa; P Tosi
Journal:  Blut       Date:  1988-07

Review 9.  The TKI Era in Chronic Leukemias.

Authors:  Danilo De Novellis; Fabiana Cacace; Valeria Caprioli; William G Wierda; Kris M Mahadeo; Francesco Paolo Tambaro
Journal:  Pharmaceutics       Date:  2021-12-20       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.